Status:
COMPLETED
Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia
Lead Sponsor:
International Agency for Research on Cancer
Collaborating Sponsors:
Kamenge University Hospital, Burundi University, Burundi
Conditions:
Cervical Neoplasia
Eligibility:
FEMALE
Phase:
NA
Brief Summary
Longitudinal study in Burundi to evaluate the effectiveness, the acceptability and safety of thermal ablation in the treatment of cervical neoplasia.
Detailed Description
The study population consisted of women with an abnormal VIA test or an abnormal colposcopy examination. A total of 86 women with lesions eligible to ablative treatment were counselled and treated by ...
Eligibility Criteria
Inclusion
- Women residing in Burundi and referred to the tertiary hospital after a positive VIA test
Exclusion
- Lesion occupying the 4 quadrants of the cervix
- Not visible squamous columnar junction (not Type 1 TZ)
- Vaginal or endocervical lesion
- Lesion subjective of cervical cancer
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT05211271
Start Date
October 1 2018
End Date
December 31 2020
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kamenge University Hospital
Bujumbura, Burundi, 2210